Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Rivaroxaban on Vascular Endothelial Function and Circulating Endothelial Progenitor Cells in Patients With Stable Atherosclerotic Vascular Diseases

NCT06986369 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT06986369
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06986369 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Rivaroxaban on Vascular Endothelial Function and Circulating Endothelial Progenitor Cells in Patients With Stable Atherosclerotic Vascular Diseases
Lead sponsor
The University of Hong Kong
Phase
Phase 4
Overall status
Completed
Start date
May 4, 2021
Completion date
March 1, 2024
Enrollment
140 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, coronary